FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1567438672> ?p ?o ?g. }

• W1567438672 endingPage "1795.e4" @default.
• W1567438672 startingPage "1786" @default.
• W1567438672 abstract "Objective To determine the age- and ethnicity-specific prevalence of decreased visual acuity (VA) in white and black preschool-aged children. Design Cross-sectional study. Participants The Baltimore Pediatric Eye Disease Study is a population-based evaluation of the prevalence of ocular disorders in children 6 through 71 months of age in Baltimore, Maryland, United States. Among 4132 children identified, 3990 eligible children (97%) were enrolled and 2546 children (62%) were examined. This report focuses on 1714 of 2546 examined children (67%) who were 30 through 71 months of age. Methods Field staff identified 63 737 occupied dwelling units in 54 census tracts. Parents or guardians of eligible participants underwent an in-home interview, and eligible children underwent a comprehensive eye examination including optotype visual acuity (VA) testing in children 30 months of age and older, with protocol-specified retesting of children with VA worse than an age-appropriate standard. Main Outcome Measures The proportion of children 30 through 71 months of age testable for VA and the proportion with decreased VA as defined by preset criteria. Results Visual acuity was testable in 1504 of 1714 children (87.7%) 30 through 71 months of age. It was decreased at the initial test (wearing glasses if brought to the clinic) in both eyes of 7 of 577 white children (1.21%; 95% confidence interval [CI], 0.49–2.50) and 13 of 725 black children (1.79%; 95% CI, 0.95–3.08), a difference that is not statistically significant. Decreased VA in both eyes after retesting was found in 3 of 598 white children (0.50%; 95% CI, 0.10–1.48) and in 8 of 757 black children (1.06%, 95% CI = 0.45, 2.10), also not statistically significantly different. Uncorrected ametropia explained the decreased VA on initial testing in 10 of the 20 children. Conclusions Decreased VA in both eyes of children 30 through 71 months of age at presentation in urban Baltimore was 1.2% among white children and 1.8% among black children. After retesting within 60 days of the initial examination and with children wearing best refractive correction, the rate of decreased VA in both eyes was 0.5% among white children and 1.1% among black children. Financial Disclosure(s) The authors have no proprietary or commercial interest in any materials discussed in this article. To determine the age- and ethnicity-specific prevalence of decreased visual acuity (VA) in white and black preschool-aged children. Cross-sectional study. The Baltimore Pediatric Eye Disease Study is a population-based evaluation of the prevalence of ocular disorders in children 6 through 71 months of age in Baltimore, Maryland, United States. Among 4132 children identified, 3990 eligible children (97%) were enrolled and 2546 children (62%) were examined. This report focuses on 1714 of 2546 examined children (67%) who were 30 through 71 months of age. Field staff identified 63 737 occupied dwelling units in 54 census tracts. Parents or guardians of eligible participants underwent an in-home interview, and eligible children underwent a comprehensive eye examination including optotype visual acuity (VA) testing in children 30 months of age and older, with protocol-specified retesting of children with VA worse than an age-appropriate standard. The proportion of children 30 through 71 months of age testable for VA and the proportion with decreased VA as defined by preset criteria. Visual acuity was testable in 1504 of 1714 children (87.7%) 30 through 71 months of age. It was decreased at the initial test (wearing glasses if brought to the clinic) in both eyes of 7 of 577 white children (1.21%; 95% confidence interval [CI], 0.49–2.50) and 13 of 725 black children (1.79%; 95% CI, 0.95–3.08), a difference that is not statistically significant. Decreased VA in both eyes after retesting was found in 3 of 598 white children (0.50%; 95% CI, 0.10–1.48) and in 8 of 757 black children (1.06%, 95% CI = 0.45, 2.10), also not statistically significantly different. Uncorrected ametropia explained the decreased VA on initial testing in 10 of the 20 children. Decreased VA in both eyes of children 30 through 71 months of age at presentation in urban Baltimore was 1.2% among white children and 1.8% among black children. After retesting within 60 days of the initial examination and with children wearing best refractive correction, the rate of decreased VA in both eyes was 0.5% among white children and 1.1% among black children." @default.
• W1567438672 created "2016-06-24" @default.
• W1567438672 creator A5000643157 @default.
• W1567438672 creator A5044950089 @default.
• W1567438672 creator A5051576162 @default.
• W1567438672 creator A5061735128 @default.
• W1567438672 creator A5079008559 @default.
• W1567438672 creator A5079217930 @default.
• W1567438672 creator A5082676836 @default.
• W1567438672 creator A5091417941 @default.
• W1567438672 date "2008-10-01" @default.
• W1567438672 modified "2023-10-01" @default.
• W1567438672 title "Prevalence of Decreased Visual Acuity among Preschool-Aged Children in an American Urban Population" @default.
• W1567438672 cites W138146716 @default.
• W1567438672 cites W157833865 @default.
• W1567438672 cites W175297244 @default.
• W1567438672 cites W1799375227 @default.
• W1567438672 cites W1980263638 @default.
• W1567438672 cites W2025718163 @default.
• W1567438672 cites W203636629 @default.
• W1567438672 cites W2055179250 @default.
• W1567438672 cites W2069024219 @default.
• W1567438672 cites W2070996797 @default.
• W1567438672 cites W2106316662 @default.
• W1567438672 cites W2118495428 @default.
• W1567438672 cites W2121176463 @default.
• W1567438672 cites W2131625520 @default.
• W1567438672 cites W2158880419 @default.
• W1567438672 cites W2172181168 @default.
• W1567438672 doi "https://doi.org/10.1016/j.ophtha.2008.04.006" @default.
• W1567438672 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2574567" @default.
• W1567438672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18538407" @default.
• W1567438672 hasPublicationYear "2008" @default.
• W1567438672 type Work @default.
• W1567438672 sameAs 1567438672 @default.
• W1567438672 citedByCount "71" @default.
• W1567438672 countsByYear W15674386722012 @default.
• W1567438672 countsByYear W15674386722013 @default.
• W1567438672 countsByYear W15674386722014 @default.
• W1567438672 countsByYear W15674386722015 @default.
• W1567438672 countsByYear W15674386722016 @default.
• W1567438672 countsByYear W15674386722017 @default.
• W1567438672 countsByYear W15674386722018 @default.
• W1567438672 countsByYear W15674386722019 @default.
• W1567438672 countsByYear W15674386722020 @default.
• W1567438672 countsByYear W15674386722021 @default.
• W1567438672 countsByYear W15674386722022 @default.
• W1567438672 countsByYear W15674386722023 @default.
• W1567438672 crossrefType "journal-article" @default.
• W1567438672 hasAuthorship W1567438672A5000643157 @default.
• W1567438672 hasAuthorship W1567438672A5044950089 @default.
• W1567438672 hasAuthorship W1567438672A5051576162 @default.
• W1567438672 hasAuthorship W1567438672A5061735128 @default.
• W1567438672 hasAuthorship W1567438672A5079008559 @default.
• W1567438672 hasAuthorship W1567438672A5079217930 @default.
• W1567438672 hasAuthorship W1567438672A5082676836 @default.
• W1567438672 hasAuthorship W1567438672A5091417941 @default.
• W1567438672 hasBestOaLocation W15674386722 @default.
• W1567438672 hasConcept C118487528 @default.
• W1567438672 hasConcept C126322002 @default.
• W1567438672 hasConcept C137403100 @default.
• W1567438672 hasConcept C144024400 @default.
• W1567438672 hasConcept C149923435 @default.
• W1567438672 hasConcept C187212893 @default.
• W1567438672 hasConcept C19165224 @default.
• W1567438672 hasConcept C2778257484 @default.
• W1567438672 hasConcept C2908647359 @default.
• W1567438672 hasConcept C44249647 @default.
• W1567438672 hasConcept C71924100 @default.
• W1567438672 hasConcept C99454951 @default.
• W1567438672 hasConceptScore W1567438672C118487528 @default.
• W1567438672 hasConceptScore W1567438672C126322002 @default.
• W1567438672 hasConceptScore W1567438672C137403100 @default.
• W1567438672 hasConceptScore W1567438672C144024400 @default.
• W1567438672 hasConceptScore W1567438672C149923435 @default.
• W1567438672 hasConceptScore W1567438672C187212893 @default.
• W1567438672 hasConceptScore W1567438672C19165224 @default.
• W1567438672 hasConceptScore W1567438672C2778257484 @default.
• W1567438672 hasConceptScore W1567438672C2908647359 @default.
• W1567438672 hasConceptScore W1567438672C44249647 @default.
• W1567438672 hasConceptScore W1567438672C71924100 @default.
• W1567438672 hasConceptScore W1567438672C99454951 @default.
• W1567438672 hasIssue "10" @default.
• W1567438672 hasLocation W15674386721 @default.
• W1567438672 hasLocation W15674386722 @default.
• W1567438672 hasLocation W15674386723 @default.
• W1567438672 hasLocation W15674386724 @default.
• W1567438672 hasOpenAccess W1567438672 @default.
• W1567438672 hasPrimaryLocation W15674386721 @default.
• W1567438672 hasRelatedWork W1984201488 @default.
• W1567438672 hasRelatedWork W2004108943 @default.
• W1567438672 hasRelatedWork W2049217636 @default.
• W1567438672 hasRelatedWork W2099510828 @default.
• W1567438672 hasRelatedWork W2121684991 @default.
• W1567438672 hasRelatedWork W2315733879 @default.
• W1567438672 hasRelatedWork W2349999257 @default.
• W1567438672 hasRelatedWork W2354275354 @default.
• W1567438672 hasRelatedWork W2519550798 @default.

• next